Mautino M R, Ramsey W J, Reiser J, Morgan R A
Clinical Gene Therapy Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-1851, USA.
Hum Gene Ther. 2000 Apr 10;11(6):895-908. doi: 10.1089/10430340050015509.
As a first step toward the development of HIV-based conditionally replicating defective interfering particles expressing trans-dominant Rev (TdRev), we studied whether mutation of the splicing signals and replacement of the RRE by the SRV-1 CTE would render these vectors less sensitive to TdRev. Vectors with mutations in the splicing signals (SD-/RRE+) yielded high titers (5 X 10(6) CFU/ml) and showed higher levels of cytoplasmic unspliced mRNA than the corresponding SD+/RRE+ vectors either in the absence of Rev, in the presence of TdRev, or in the presence of both TdRev and Rev. Proviral copies of SD-/RRE+ vectors were rescued more efficiently than SD+/RRE+ vectors when TdRev was expressed. Vectors with the SRV-1 CTE (SD+/CTE+ and SD-/CTE+) expressed high levels of cytoplasmic unspliced mRNA in the absence of Rev expression. Titers obtained with the SD-/CTE+ vectors (10(6) CFU/ml) were higher than the titers obtained with SD+/CTE+ vectors. We also tested the effect of other structural modifications such as the orientation of the expression cassette and the presence of the central polypurine tract (cPPT/CTS). We show that an expression cassette cloned in the reverse orientation with respect to the LTRs or elimination of the cPPT/CTS element severely affected vector titers. We also demonstrated that these vectors can be efficiently mobilized from their proviral state by HIV trans-complementing functions, and transduced into secondary target cells without suffering any genomic rearrangement.
作为开发基于HIV的表达反式显性Rev(TdRev)的条件性复制缺陷干扰颗粒的第一步,我们研究了剪接信号的突变以及用SRV-1 CTE替代RRE是否会使这些载体对TdRev不那么敏感。剪接信号发生突变(SD-/RRE+)的载体产生了高滴度(5×10⁶ CFU/ml),并且在不存在Rev、存在TdRev或同时存在TdRev和Rev的情况下,与相应的SD+/RRE+载体相比,显示出更高水平的细胞质未剪接mRNA。当表达TdRev时,SD-/RRE+载体的前病毒拷贝比SD+/RRE+载体更有效地被拯救。具有SRV-1 CTE(SD+/CTE+和SD-/CTE+)的载体在不存在Rev表达的情况下表达高水平的细胞质未剪接mRNA。用SD-/CTE+载体获得的滴度(10⁶ CFU/ml)高于用SD+/CTE+载体获得的滴度。我们还测试了其他结构修饰的效果,如表达盒的方向和中央多聚嘌呤序列(cPPT/CTS)的存在。我们表明,相对于LTR以反向克隆的表达盒或消除cPPT/CTS元件会严重影响载体滴度。我们还证明,这些载体可以通过HIV反式互补功能有效地从其前病毒状态动员出来,并转导到次级靶细胞中而不会发生任何基因组重排。